Cargando…
Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis
BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [(18) F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracel...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875899/ https://www.ncbi.nlm.nih.gov/pubmed/24088510 http://dx.doi.org/10.1186/2191-219X-3-69 |
_version_ | 1782297425926422528 |
---|---|
author | Walker, Matthew D Dinelle, Katherine Kornelsen, Rick Lee, Anna Farrer, Matthew J Stoessl, A Jon Sossi, Vesna |
author_facet | Walker, Matthew D Dinelle, Katherine Kornelsen, Rick Lee, Anna Farrer, Matthew J Stoessl, A Jon Sossi, Vesna |
author_sort | Walker, Matthew D |
collection | PubMed |
description | BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [(18) F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracellular fluid measured by microdialysis to aid in the interpretation of data from both techniques. METHODS: [(18) F]FDOPA PET imaging and microdialysis measurements were performed in unilaterally 6-hydroxydopamine-lesioned rats (n = 8) and normal control rats (n = 3). Microdialysis testing included baseline measurements and measurements following acute administration of LDOPA. PET imaging was also performed using [(11)C]dihydrotetrabenazine (DTBZ), which is a ligand for the vesicular monoamine transporter marker and allowed assessment of denervation severity. RESULTS: The different methods provided highly correlated data. Lesioned rats had reduced DA metabolite concentrations ipsilateral to the lesion (p < 0.05 compared to controls), with the concentration being correlated with FDOPA's effective distribution volume ratio (EDVR; r = 0.86, p < 0.01) and DTBZ's binding potential (BP(ND); r = 0.89, p < 0.01). The DA metabolite concentration in the contralateral striatum of severely (>80%) lesioned rats was lower (p < 0.05) than that of less severely lesioned rats (<80%) and was correlated with the ipsilateral PET measures (r = 0.89, p < 0.01 for BP(ND)) but not with the contralateral PET measures. EDVR and BP(ND) in the contralateral striatum were not different from controls and were not correlated with the denervation severity. CONCLUSIONS: The demonstrated strong correlations between the PET and microdialysis measures can aid in the interpretation of [(18) F]FDOPA-derived kinetic parameters and help compare results from different studies. The contralateral striatum was affected by the lesioning and so cannot always serve as an unaffected control. |
format | Online Article Text |
id | pubmed-3875899 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer |
record_format | MEDLINE/PubMed |
spelling | pubmed-38758992013-12-31 Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis Walker, Matthew D Dinelle, Katherine Kornelsen, Rick Lee, Anna Farrer, Matthew J Stoessl, A Jon Sossi, Vesna EJNMMI Res Original Research BACKGROUND: [(18) F]fluorodopa (FDOPA) positron emission tomography (PET) allows assessment of levodopa (LDOPA) metabolism and is widely used to study Parkinson's disease. We examined how [(18) F]FDOPA PET-derived kinetic parameters relate the dopamine (DA) and DA metabolite content of extracellular fluid measured by microdialysis to aid in the interpretation of data from both techniques. METHODS: [(18) F]FDOPA PET imaging and microdialysis measurements were performed in unilaterally 6-hydroxydopamine-lesioned rats (n = 8) and normal control rats (n = 3). Microdialysis testing included baseline measurements and measurements following acute administration of LDOPA. PET imaging was also performed using [(11)C]dihydrotetrabenazine (DTBZ), which is a ligand for the vesicular monoamine transporter marker and allowed assessment of denervation severity. RESULTS: The different methods provided highly correlated data. Lesioned rats had reduced DA metabolite concentrations ipsilateral to the lesion (p < 0.05 compared to controls), with the concentration being correlated with FDOPA's effective distribution volume ratio (EDVR; r = 0.86, p < 0.01) and DTBZ's binding potential (BP(ND); r = 0.89, p < 0.01). The DA metabolite concentration in the contralateral striatum of severely (>80%) lesioned rats was lower (p < 0.05) than that of less severely lesioned rats (<80%) and was correlated with the ipsilateral PET measures (r = 0.89, p < 0.01 for BP(ND)) but not with the contralateral PET measures. EDVR and BP(ND) in the contralateral striatum were not different from controls and were not correlated with the denervation severity. CONCLUSIONS: The demonstrated strong correlations between the PET and microdialysis measures can aid in the interpretation of [(18) F]FDOPA-derived kinetic parameters and help compare results from different studies. The contralateral striatum was affected by the lesioning and so cannot always serve as an unaffected control. Springer 2013-10-02 /pmc/articles/PMC3875899/ /pubmed/24088510 http://dx.doi.org/10.1186/2191-219X-3-69 Text en Copyright © 2013 Walker et al.; licensee Springer. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Walker, Matthew D Dinelle, Katherine Kornelsen, Rick Lee, Anna Farrer, Matthew J Stoessl, A Jon Sossi, Vesna Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis |
title | Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis |
title_full | Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis |
title_fullStr | Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis |
title_full_unstemmed | Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis |
title_short | Measuring dopaminergic function in the 6-OHDA-lesioned rat: a comparison of PET and microdialysis |
title_sort | measuring dopaminergic function in the 6-ohda-lesioned rat: a comparison of pet and microdialysis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875899/ https://www.ncbi.nlm.nih.gov/pubmed/24088510 http://dx.doi.org/10.1186/2191-219X-3-69 |
work_keys_str_mv | AT walkermatthewd measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis AT dinellekatherine measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis AT kornelsenrick measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis AT leeanna measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis AT farrermatthewj measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis AT stoesslajon measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis AT sossivesna measuringdopaminergicfunctioninthe6ohdalesionedratacomparisonofpetandmicrodialysis |